Overview

D600


Related Overviews

 

'D600' can also refer to...

D600

Taliesin (d. c.600)

David, Saint (d. c.600)

Comgall, St (d. c.600)

600. D. W. to Catherine Clarkson

Finan Cam (d. c.600)

600 To M. d'Arblay: Dunkirk, 6 July 1812

The Post-Saladoid in the Lesser Antilles (A.D. 600/800–1492)

BRAF V600D mutation in a paediatric high-grade glioma

Characterisation of MCP-600D and MCP-700D thermoluminescence detectors and their applicability for photoneutron detection

Characterizing Community-Center (Village) Formation in the VEP Study Area, a.d. 600–1280

LBA6_PRCOMBI-AD: Adjuvant dabrafenib (D) plus trametinib (T) for resected stage III BRAF V600E/K–mutant melanoma

1220PDPhase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

Hylton v Jamaica, Merits, UN Doc CCPR/C/57/D/600/1994, Communication No 600/1994, IHRL 2193 (UNHRC 1996), 16th July 1996, United Nations Human Rights Committee [UNHRC]

A Randomized Controlled Trial on Safety and Efficacy of Single Intramuscular versus Staggered Oral Dose of 600 000IU Vitamin D in Treatment of Nutritional Rickets

Adam Herring. Art and Writing in the Maya Cities, a.d. 600–800: A Poetics of Line. New York: Cambridge University Press. 2005. Pp. xvi, 316. $85.00

Health-related quality-of-life (HRQOL) impact of dabrafenib (D) and trametinib (T) vs BRAF inhibitor (BRAFi) monotherapy by lactate dehydrogenase (LDH) in patients (pts) with BRAF V600–mutant melanoma

Analysis of patient-reported outcomes by disease progression status in patients (pts) with BRAF V600–mutant metastatic melanoma in the COMBI-d and COMBI-v trials

LBA51Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC)

 

More Like This

Show all results sharing this subject:

  • Chemistry

GO

Show Summary Details

Quick Reference

Gallopamil, 5‐methoxyverapamil, α‐(3‐ [2‐(3,4‐dimethoxyphenyl)ethyl] methylamino propyl)‐3,4,5‐trimethoxy‐α‐(1‐methylethyl) benzeneacetonitrile; a drug used in the laboratory to block transport of calcium ions in biological membranes; it is more potent than verapamil.

Subjects: Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.